Monday, August 15, 2011

Pharmaceutical Manufacturers Shut Down Facebook Pages

The Washington Post is reporting that several pharmaceutical manufacturers are choosing to shut down Facebook pages rather than comply with new rules that state that they have to allow user to post comments on the "walls" of pages devoted to particular disease states and patient communities.
The industry is concerned that users might write about bad side effects, promote off-label use or make inappropriate statements about a product, and that the comments could raise concerns from government regulators.

Facebook will continue to allow companies to block comments on pages related to specific prescription products.


No comments:

Post a Comment

We ask that you please include your real name and your school affiliation when leaving comments. This will make it easier for people with similar interests to identify you. It will also help us keep down the amount of SPAM that can easily clog the comments section of a blog.